Centrum® Silver A multivitamin complex from A to Zinc (Centrum® Silver Multivitamin complex from A to Zinc)

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.003657.08.17
Date of registration and renewal:21.08.2017
Dosage form: & nbspTablets coated with a film membrane with a mass of 1264.0 mg ± 10%
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes
Composition: & nbspDibasic calcium phosphate, magnesium oxide, L-ascorbic acid, carrier microcrystalline cellulose, potassium chloride, coloring Opadry II gray (carrier hydroxypropylmethylcellulose, colorant titanium dioxide, maltodextrin, polydextrose carrier agent the flowing talc, medium-chain triglycerides of coconut and palm kernel oils, dye coal vegetative), DL-alpha-tocopherol acetate, stabilizer E1202, nicotinamide, calcium d-pantothenate, iron (II) fumarate, zinc oxide, manganese sulfate, magnesium stearate emulsifier, anti- Lying silica amorphous, beta-carotene, pyridoxine hydrochloride, thiamine mononitrate, riboflavin, gelatin, copper sulfate, retinol acetate, folic acid, chromium chloride, sodium molybdate, potassium iodide, D-biotin, sodium selenate, phylloquinone, antioxidant butylhydroxytoluene, cholecalciferol , cyanocobalamin.
Scope: & nbspFor the realization of an additional source of vitamins (A, E, D, K, C, B1, B2, B6, B12, biotin, folic acid, pantothenic acid, nicotinamide) and mineral substances ( calcium, chromium, copper, iodine, iron, magnesium, manganese, molybdenum, phosphorus, selenium, zinc) for people over 50 years old.
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance to the components of the product. Before use, it is recommended to consult a doctor.
Shelf life:24 months.
Storage conditions:Store in a place inaccessible to children, at a temperature not exceeding 25 ° C. After use, close the lid tightly.
Research protocols:Expert Opinion FGBUN "FIC Nutrition and Biotechnology" No. 529 / E-101 / b-17 dated 02.02.2017, the protocol of laboratory studies of the City Clinical Hospital of Moscow "The Center for Drug Supply and Quality Control of the Moscow City Health Department" No. 2/00000127 dated March 31, 2017
Recipient:Pfizer Innovations, LLCPfizer Innovations, LLC Russian Federation
Information update date: & nbsp10.11.2017
Instructions
Up